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In healthy human subjects, the simultaneous aerosol administration of histamine and
methacholine results in a pronounced decrease in maximum flow rates on partial expiratory
flow-volume (PEFV) curves. When given alone in the same concentrations, these drugs
produced no or minimal decreases in flow rates. The results suggest an interaction ofhistamine
and cholinergic stimuli on airway smooth muscle (ASM). This mechanism might explain many
experiments where vagal blockade diminished or abolished ASM response to histamine and
other stimuli, simply by interfering with histamine-cholinergic interaction at the ASM level.
These findings confirm similar findings of animal in vitro experiments. The experiments clearly
confirm the sensitivity and value of assessing drug effects prior to a deep breath. Flow-rate
changes after a full inspiration, taken from the maximum expiratory flow-volume (MEFV)
curve, show either no relationship to the concentration ofinhaled methacholine or significantly
less effect than that seen on the PEFV curve.
In spontaneously breathing guinea pigs, airway smooth muscle responses to a
contracting agent, histamine, are potentiated by drugs which enhance cholinergic
stimuli (physostigmine) and block ,B-adrenergic stimuli (propranolol) while they are
inhibited by drugs which block cholinergic stimuli (atropine) and stimulate ,B-adren-
ergic receptors (isoproterenol) (1,2). These findings led to the hypothesis that au-
tonomic transmitter substances from vagal and adrenergic nerve endings, and from
circulating catecholamines, interact with histamine at the smooth muscle cell level,
leading to enhancement or inhibition of the contractor action of histamine as a func-
tion of the balance of the autonomic stimuli. Experiments with isolated tracheal
muscle ofguinea pigs have given support to this hypothesis (3,4). Indirect support for
such a mechanism of interaction in man is derived from experiments in which
propranolol potentiated airway constrictor responses to cigarette smoke in healthy
persons (5). This result suggested that physiologic levels off-adrenergic stimulation
normally protect airway smooth muscle, in part, against the effect of constrictor
agents. The present study demonstrates, in man, a potentiation of histamine
responses by simultaneous administration of methacholine, an acetylcholine analog,
and thus provides support for interaction between cholinergic stimulation and his-
tamine on smooth muscle. In addition, the results confirm the superiority of
maximum expiratory flow rate measurements without maximum inspiration [partial
expiratory flow-volume (PEFV) curve] over maximum expiratory flow-volume
(MEFV) curves in detecting and quantitating airway constrictor responses in man.
SUBJECTS AND METHODS
We studied seven healthy adult subjects aged 21 to 32 years, all nonsmokers who
denied present respiratory symptoms. To assess airway caliber, we recorded partial
'A preliminary communication has been published (Physiologist 15, 219 (1972)). Supported in part by
the National Heart and Lung Institute (Grant HE-14179, SCOR Program).
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expiratory flow-volume (PEFV) curves with a pneumotachograph-electronic integra-
tor device (6) and a Brush 500 high performance XY recorder (Gould, Inc.).
On each occasion the subject inspired to about 65% of forced vital capacity (FVC)
rather than to total lung capacity (TLC) and next performed a fast expiration from
that volume level to residual volume. The record of this expiration is the PEFV
curve. The subject then inspired to TLC and performed a full forced expiratory ma-
neuver, during which the maximum expiratory flow-volume (MEFV) curve was
recorded. The response characteristics of the XY recorder are sufficient for accurate
reproduction of MEFV and PEFV curves, in comparison with curves recorded on a
storage oscilloscope, if one chooses excursions of 1 in. for 2 liters/sec on the flow
axis, and
1 in. for
1 liter on the volume axis. From each set of curves we measured
expiratory flow rates at 40% of FVC, i.e., at TLC minus 60% of the control FVC.
These were measured on PEFV [MEF 40%(P)] as well as MEFV (MEF 40%) curves.
In addition, a time marker set at
1 sec on the MEFV curve allowed reading of the
FEVy1o value for each blow.
Aerosol Administration
We used a D30 aerosol generator (7) which produced 0.25 ml/min of aerosol at a
disruptive pressure of 15 psi. More than 95% of the particles produced by this
generator have a diameter of 0.3,m or less; their mean size is about 0.05,um (7). The
aerosol was temporarily stored in an open tube on the inspiratory side of a Collins J
valve. The concentrations of solutions used were determined for each subject by de-
termining the threshold dose for both histamine and methacholine. Concentrations
around the threshold dose were selected for each of the two drugs. The threshold
dose was defined as the concentration of each drug which caused a decrease of
MEFV 40%(P) greater than 0.3 liters/sec.
Initially each subject performed three baseline PEFV and MEFV curves. The
aerosol was then inhaled for 30 sec, and further recordings were made immediately
after inhalation and again 2 and 4 min later.
On each day solutions of histamine, methacholine, and histamine and
methacholine combined were inhaled. Two hours elapsed between inhalations. This
routine was repeated on 2 subsequent days, the order of the aerosols being varied ac-
cording to a Latin square arrangement to eliminate any possible bias due to circadian
variation in airway reactivity (8). Neither the subject nor the person who analyzed
the results was aware of the contents of the aerosol. In several subjects, solutions of
normal saline were included in the protocol.
For each inhalation experiment, the average flow rates from the three control
curves were used as the baseline value. The absolute difference between the flow
rates after inhalation and the baseline value was obtained at each time interval and
averaged for each of the three occasions that each drug was inhaled.
RESULTS
Recordings from a typical experiment are shown in Fig. 1. In the control experi-
ment, maximum flow rates at low lung volumes on the MEFV curves were superim-
posed on those recorded during the preceding forced expiration, made from a lung
volume of about 65% VC. Immediately after inhalation of the constrictor aerosol,
maximum flow rates during the first forced expiration (from a lung volume of about 1
liter less than TLC) were greatly decreased. The resulting PEFV curve terminates at
TLC minus 3.2 liters, i.e., residual volume is increased. Next, the subject inspired to
TLC and performed the MEFV curve maneuver, during which flow rates at similar
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FIG. 1. Control and postexposure MEFV and PEFV curves in a healthy subject. The intersection ofthe
curves and the vertical interrupted line indicate MEF 40% (at TLC less 60% of the control FVC). The
vertical arrows indicate the position oftheone-second marker.
volumes were less than control values but much higher than thoseon theimmediately
preceding PEFV curve. Thus, after a single maximum inspiration, the flow rate
decrement after a constrictor aerosol was greatly diminished. Most likely as a result
ofthe maximum inspiration, measurements made from the MEFV curve (FEV1.0 and
MEF 40%) decrease less than the flow measurement from the PEFV curve [MEF
40%(P)], in comparison with control values (for numerical results, see box in Fig. 1
and, also, Table 1).
Individual subjects appeared to differ in the extent to which a deep inspiration
abolished the effect ofthe constrictor aerosol on maximum flow rates. This difference
is demonstrated by the relationship between the dose of methacholine (i.e., the
concentration in the nebulized fluid) and the responses of FEVI.0, MEF 40%, and
MEF 40%(P) in Figs. 2 and 3. In one subject (Fig. 2) there was a high correlation
between the methacholine dose and the response, no matter which of the three
measures was used. However, the changes of MEF 40%(P) were greater than those
of MEF 40%, and the latter were greater than the changes of FEV10O. In contrast,
only changes of MEF 40%(P) correlated with the dose ofmethacholine in the subject
ofFig. 3. The measurements recorded after a full inspiration (MEF 40% and FEV .0)
showed no relationship to the concentrations of methacholine inhaled, suggesting
that in this subject a deep inspiration often completely abolished the constrictor
response. Three out of the seven subjects in the present study gave dose-response
relationships similar to those in Fig. 3. Therefore, we used MEF 40%(P) measure-
TABLE 1
Relative Changes in Measures ofAirway Responses in Two Subjects for All Challenges
where MEF 40% (P) Decreased by 20-40% ofControl Values
Subject #I Subject #2
(13 challenges) (15 challenges)
Decrease Decrease
Before After (%) Before After (%)
FEVy (liters) 3.21 3.10 3.4 5.41 5.34 1.3
MEF 40% (liters/sec) 2.84 2.36 16.9 5.63 5.15 8.5
MEF40%(P)(liters/sec) 2.81 2.07 26.3 5.02 3.65 27;3
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FIG. 2. Dose-response relationships in a healthy subject to aerosol methacholine inhaled in various
concentrations for 30 sec. The percentage decreases in FEV1, MEF 40%, and MEF 40%(P) are shown.
Linear regression analysis was performed for each measurement (shown as continuous line). The correla-
tion coefficients for each analysis are: FEV,, +0.83; MEF 40%, +0.76; MEF 40%(P), +0.84.
ments exclusively to assess the possible interaction between histamine and
methacholine, since this was the only measure which gave dose-related responses in
methacholine experiments in all subjects.
Interaction
The results of one subject are shown in Fig. 4. Histamine (5 mg/ml) and
methacholine (12.5 mg/ml) inhaled separately, resulted in changes in flow rates
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FIG. 3. As Fig. 2; the respective correlation coefficients are: FEV,, 0.00; MEF 40%, 0.00;
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FIG. 4. Changes in flow rates on PEFV curves after 30-sec inhalation of histamine and methacholine
administered separately and together in a healthy subject. (o---o) Saline control; (o---o) histamine alone;
(o----) methacholine alone; (A-A) histamine and methacholine together. The hatched area indicates the
challenge.
similar to those seen after saline. However, histamine and methacholine
administered together in the same concentrations resulted in a decrease in flow rates
which was, at most time intervals, at least three times the algebraic sum of the
changes to the drug administered separately. Similar results are shown in another
subject in Fig. 5.
The mean data in the seven subjects are shown in Fig. 6. Histamine inhalation
resulted in a slight but not significant increase in flow rates. Methacholine decreased
flow rates slightly; the decrease compared to controls was significant (p = 0.01) im-
mediately after inhalation but not significant later on. However, saline aerosol gave a
similar response. The changes in flow rates after histamine and methacholine
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FIG. 5. As Fig. 4; for another subject.
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FIG. 6. As Fig. 4; for all seven healthy subjects. Values are shown as means 4 SEM.
administered together were considerably greater than the algebraic sum of the
effects ofthe drugs administered separately (p <0.005 at 0 and 4 mm; p <0.02 at 2
mi). For example, 4 mi after the inhalation, the algebraic sum of the flow rate
changes seen after the drugs given separately is +0.01 liters/sec, as compared to
-0.49 liters/sec after thedrugs given together.
Simultaneous administration of the two drugs was essential to the demonstration
of interaction. Earlier experiments had failed to demonstrate any interaction when
the drugs were administered sequentially.
DISCUSSION
We have shown that simultaneous administration of histamine and methacholine
by inhalation of an aerosol results in a pronounced decrease of maximum expiratory
flow rates at small lung volumes. When given alone in the same doses, the two drugs
produced no or minimal decreases ofthese flow rates when compared to the effect of
saline aerosol. After inhalation of the mixture, flow rates first rapidly decrease and
then return to normal within 20 mi. Since the reversion offlow rates to normal is not
accompanied by expectoration of mucus, their reduction is most likely due to
contraction ofairway smooth muscle (ASM) with reduced airway caliber as a result.
The fact that significant effects were observed with the two drugs together, while
each drug given separately had at most minimal effects, points to a supraadditive
type ofinteraction between the two agents.
Animal experiments support this conclusion. Histamine and methacholine both
contract ASM of many species, including man (9), in vitro. In in vitro ASM prepara-
tions ofguinea pigs, constrictor effects ofhistamine are potentiated by methacholine
as well as by stimulation of cholinergic nerve fibers to the isolated trachea (3,4). In
these preparations, potentiation ofhistamine effects can best be explained by interac-
tion between histamine and cholinergic stimuli on smooth muscle cells in airways
(10). The analogy between the interaction observed in in vitro ASM preparations and
the potentiation of histamine-induced airway constriction by methacholine in the
present experiments in intact man is striking. Thus, the simplest explanation of the
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latter is that interaction between histamine and cholinergic stimuli on ASM occurs
not only in isolated guinea pig trachea but also in the airways ofintact man.
It has long been recognized that vagal efferent stimulation leads to airway
constriction through contraction of ASM. In recent years several experiments,
including those ofNadel, Gold, and their co-workers, have shown that vagal blockade
by atropine, by cooling of the nerves, or by vagotomy reduces ASM responses to
histamine in man (11) and to histamine and other airway constrictor stimuli in ani-
mals (12-15). These investigators interpret their results as indicating that the direct
action of histamine on ASM is reinforced by a bronchoconstrictor reflex, with its
efferent pathway in the vagal nerves. This hypothesis can explain why vagal blockade
diminished the effect of histamine. However, the afferent pathways of the broncho-
constrictor reflex have not been clearly identified. The existence of "irritant recep-
tors" in airways has been postulated from physiological experiments with irritants
but these receptors have not been identified morphologically. Afferent stimuli might
also originate in contracting airways, perhaps as a result of mechanical deformation
ofmucosal nerve endings (16).
The most convincing evidence for the existence of bronchoconstrictor reflexes
comes from experiments in dogs, where slight contraction of an isolated cervical
tracheal segment occurred within seconds after an injection ofhistamine into a bron-
chial artery (12). Unilateral challenges in dogs with separate ventilation of the two
lungs suggest that vagally mediated reflexes determine a major degree of the ASM
constrictor response to histamine and allergen challenge (13). However, similar ex-
periments in two asthmatic humans have given negative results (17). Appropriate
allergen challenge, sufficient to cause a moderate delay ofnitrogen clearance on the
challenged side, failed to produce a demonstrable effect in the contralateral un-
challenged lung. As has previously been argued (13), these subjects were premedi-
cated with opiates, scopolamine, and local anesthesia to the airway, and this pre-
medication may have been sufficient to abolish all vagal activity.
The absence of a demonstrable effect in the unchallenged contralateral lung im-
plies either that reflexes play an unimportant role in allergic airway reactions in man
or that vagal blockade was present in these studies. Ifvagal blockade is accepted as
the explanation of the absence of a contralateral response, then the moderate effect
seen on the challenged side must be due entirely to the local action ofreleased media-
tors of the allergic reactions, as it is hard to argue that reflex vagal activity would be
abolished on one side only. Thus, although this study (17) does not allow any conclu-
sions regarding the contribution of the reflex vagal activity to the allergic reaction, it
implies that a moderate ASM response may be produced by the local action of
released mediators alone. These same studies demonstrated a decreased sensitivity
of the airways after the premedication in that it was necessary to use "allergen
concentrations ten times larger than those needed to produce asthma . .. when the
subjects were not anesthetized" (17). This decreased sensitivity might be explained
by the reflex theory.
However, interaction between physiological levels of cholinergic stimuli (vagal
tone) and histamine at the level of ASM cells offers an alternative hypothesis to
explain this and many other experiments in which efferent vagal blockade diminishes
or abolishes airway constriction induced by histamine or allergens. It is also a more
comprehensive hypothesis than the reflex theory because it explains not only why
vagal blockade reduces but also why physostigmine in guinea pigs intensifies his-
tamine-induced airway constriction (2). The reflex theory cannot account for the
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potentiation of histamine responses in isolated trachea-nerve preparations by
constant levels ofvagal nerve stimulation (3,4). The present results in intact humans
are similar to those obtained with these isolated preparations. Thus, we believe that
interaction between cholinergic stimuli and histamine may occur in intact humans. In
this concept, vagal blockade reduces histamine-mediated responses by abolishing
histamine-cholinergic interaction.
The mechanism of interaction between different chemical stimuli on ASM cells is
not known. Interactions might occur at receptor sites on the cells. It may also involve
common actions of chemical stimuli, mediated via different receptors, on in-
tracellular processes involved in the contraction and relaxation ofthe smooth muscle
filaments, such as intracellular transport of calcium or intracellular levels of cyclic
nucleotides.
Since we measured maximum expiratory flow rates on PEFV curves, as well as on
MEFV curves recorded immediately after a PEFV curve, our data give further in-
formation on the effects of a single deep inspiration on changes in airway caliber in-
duced by bronchoconstrictor agents (18). In all subjects, flow rates decreased more
on the PEFV curves than on the MEFV curves (Fig. 1). In three subjects, the effect
ofone deep inspiration was so marked that there was no relationship between inhaled
methacholine concentrations and flow rates measured after a deep inspiration (Fig.
3). In the remaining four subjects, the inhaled methacholine concentrations corre-
lated significantly with flow rates measured after a deep inspiration, but flow rates
measured prior to the deep inspirations always showed the greatest change (Fig. 2).
These differences in flow rate changes on MEFV and PEFV curves probably reflect
an effect oflung volume history on ASM tone. Such a volume history effect, resulting
in higher airway resistance at a given volume when previous volumes were small, has
been demonstrated in normal subjects (19). It is abolished by atropine (20) and
intensified by methacholine (18). The greater sensitivity of PEFV curves in assessing
airway constrictor effects in our experiments may, in part, be due to this effect of
methacholine. However, PEFV curves are also more sensitive than FEV1.0 and
MEFV curves in assessing responses in airway constrictor agents other than
methacholine (5,21). Apparently, a single deep inspiration considerably increases
airway caliber regardless ofthe agent which reduced it.
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